Principal Investigators

    Dr Jenny Gunnersen


    University of Melbourne

    Contact information of lead PI



    Title of project or programme

    Investigating secondary effects of a promising therapeutic strategy for Alzheimer's disease

    Source of funding information

    National Health and Medical Research Council

    Total sum awarded (Euro)

    € 469,450

    Start date of award


    Total duration of award in years



    Research Abstract

    Synapses transfer information between neurons in the brain. In Alzheimer’s disease (AD), synapse loss results in dementia therefore it is imperative that any potential therapeutic drugs do not inadvertently cause further synapse loss. Drugs aimed at blocking production of toxic protein fragments in AD might have adverse secondary effects on synapse development and function. This research will determine whether this is the case and inform new therapeutic approaches aimed at minimizing side effects.

    Further information available at:

Types: Investments < €500k
Member States: Australia
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF